December 12, 2021
Indivumed is pleased to announce that Dr. Stephan Schüller has joined Indivumed as Chief Financial Officer. With more than 30 years of experience as a business executive, professor, and board member, Dr. Schüller brings highly valuable knowledge and perspectives to Indivumed.
“It is a pleasure to support Indivumed in the current growth phase,” said Dr. Schüller. “Indivumed has a unique opportunity to realize better cancer care by data- and AI-driven precision oncology and it is a great privilege for me that I am allowed to contribute from a financial perspective realizing the full value of this amazing company.”
A prominent financial leader, Dr. Schüller studied business economics at the Westfälische Wilhelms-Universität in Münster, Germany. Since 1992, Schüller has taught business politics of financial institutions at the University of Duisburg-Essen and the Mercator School of Management.
Prior to joining Indivumed, Dr. Schüller was the CEO of Bankhaus Lampe KG in Düsseldorf and Vereins-und Westbank AG in Hamburg, respectively. Dr. Schüller was also a board member for several financial institutions, including Vereins-und Westbank AG in Hamburg and HypoVereinsbank AG (formerly Bayrische Vereinsbank) in München.
“I am honored that Stephan Schüller has decided to join Indivumed. With him we could win a worldwide highly respected financial expert to support Indivumed in becoming the leading AI- and data-driven company for precision oncology.” said Dr. Hartmut Juhl, Founder and CEO of Indivumed.